Fortfahren mit
M4141
Methansulfonsäure -Lösung
4 M (with 0.2% (w/v) tryptamine)
Synonym(e):
Sulfomethane
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Packungsgröße | SKU | Verfügbarkeit | Preis |
|---|---|---|---|
| 10 x 2 mL | Warenkorb auf Verfügbarkeit prüfen | € 430,00 |
Über diesen Artikel
Lineare Formel:
CH3SO3H
CAS-Nummer:
Molekulargewicht:
96.11
UNSPSC Code:
12352209
NACRES:
NA.21
PubChem Substance ID:
EC Number:
200-898-6
Beilstein/REAXYS Number:
1446024
MDL number:
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenform
liquid
Quality Level
concentration
4 M (with 0.2% (w/v) tryptamine)
storage temp.
2-8°C
SMILES string
CS(O)(=O)=O
InChI
1S/CH4O3S/c1-5(2,3)4/h1H3,(H,2,3,4)
InChI key
AFVFQIVMOAPDHO-UHFFFAOYSA-N
Application
For complete protein and peptide hydrolysis with tryptophan recovery. After hydrolysis the samples are diluted prior to amino acid analysis.
Packaging
Ampules sealed under argon.
Disclaimer
air sensitive, store under inert conditions
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| concentration 4 M (with 0.2% (w/v) tryptamine) | concentration 70 wt. % in H2O | concentration 0.1 M CH3SO3H in water (0.1N) | concentration - |
| Quality Level 200 | Quality Level 200 | Quality Level 100 | Quality Level 100 |
| form liquid | form - | form - | form liquid |
| storage temp. 2-8°C | storage temp. - | storage temp. - | storage temp. - |
Still not finding the right product?
Explore all of our products under Methansulfonsäure -Lösung
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - Skin Sens. 1 - STOT SE 3
target_organs
Respiratory system
Lagerklasse
8A - Combustible corrosive hazardous materials
wgk
WGK 2
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Gulfam Ahmad et al.
Frontiers in pharmacology, 11, 556020-556020 (2020-10-13)
Chronic inflammatory bowel disease (IBD) is a condition with multifactorial pathophysiology. To date, there is no permanent cure and the disease is primarily managed by immunosuppressive drugs; long-term use promotes serious side effects including increased risk malignancies. The current study
Luke F Gamon et al.
Redox biology, 36, 101586-101586 (2020-06-07)
The precise characterization and quantification of oxidative protein damage is a significant challenge due to the low abundance, large variety, and heterogeneity of modifications. Mass spectrometry (MS)-based techniques at the peptide level (proteomics) provide a detailed but limited picture due
Chris Twelves et al.
Breast cancer research and treatment, 148(3), 553-561 (2014-11-09)
Data from two phase 3 studies of eribulin were pooled in analyses initially requested by the European Medicines Agency to assess whether specific patient subgroups, previously treated with an anthracycline and a taxane, benefited from eribulin. Study 305/EMBRACE included women
Global Trade Item Number
| SKU | GTIN |
|---|---|
| M4141-10X2ML | 04061837841088 |